←Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer, PAOLA-1 Combination
Isabelle Ray-Coquard
MD, PhD
🏢Centre Leon Berard / GINECO🌐France
Professor of Medical Oncology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Isabelle Ray-Coquard led the PAOLA-1 trial combining olaparib with bevacizumab maintenance after front-line therapy, establishing a new standard for HRD-positive ovarian cancer. She is an expert on rare gynecologic tumors and contributes to ENGOT trial leadership.
Share:
🧪Research Fields 研究领域
PAOLA-1 olaparib bevacizumab
rare gynecologic tumors
sex cord stromal
GINECO trials
ENGOT leadership
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Isabelle Ray-Coquard 的研究动态
Follow Isabelle Ray-Coquard's research updates
留下邮箱，当我们发布与 Isabelle Ray-Coquard（Centre Leon Berard / GINECO）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment